1 Market Overview 1.1 Nuclear Medicine-Radiopharmaceuticals Introduction 1.2 Market Analysis by Type 1.2.1 Diagnostic Medicine 1.2.2 Therapeutic Medicine 1.3 Market Analysis by Application 1.3.1 SPECT 1.3.2 PET 1.3.3 Therapeutic 1.4 Market Analysis by Region 1.4.1 United States Market States and Outlook (2014-2026F) 1.4.2 Europe Market States and Outlook (2014-2026F) 1.4.3 China Market States and Outlook (2014-2026F) 1.4.4 Japan Market States and Outlook (2014-2026F) 1.4.5 Southeast Asia Market States and Outlook (2014-2026F) 1.4.6 India Market States and Outlook (2014-2026F) 1.4.7 Brazil Market States and Outlook (2014-2026F) 1.4.8 GCC Countries Market States and Outlook (2014-2026F) 1.5 Market Dynamics and Development 1.5.1 Merger, Acquisition and New Investment 1.5.2 Market SWOT Analysis 1.5.3 Drivers 1.5.4 Limitations 1.5.5 Opportunities and Development Trends 1.6 Global Nuclear Medicine-Radiopharmaceuticals Market Size Analysis from 2014 to 2026 1.6.1 Global Nuclear Medicine-Radiopharmaceuticals Market Size Analysis from 2014 to 2026 by Consumption Volume 1.6.2 Global Nuclear Medicine-Radiopharmaceuticals Market Size Analysis from 2014 to 2026 by Value 1.6.3 Global Nuclear Medicine-Radiopharmaceuticals Price Trends Analysis from 2014 to 2026 2 Global Nuclear Medicine-Radiopharmaceuticals Competition by Types, Applications, and Top Regions and Countries 2.1 Global Nuclear Medicine-Radiopharmaceuticals (Volume and Value) by Type 2.1.1 Global Nuclear Medicine-Radiopharmaceuticals Consumption and Market Share by Type (2014-2019) 2.1.2 Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Type (2014-2019) 2.2 Global Nuclear Medicine-Radiopharmaceuticals (Volume and Value) by Application 2.2.1 Global Nuclear Medicine-Radiopharmaceuticals Consumption and Market Share by Application (2014-2019) 2.2.2 Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Application (2014-2019) 2.3 Global Nuclear Medicine-Radiopharmaceuticals (Volume and Value) by Region 2.3.1 Global Nuclear Medicine-Radiopharmaceuticals Consumption and Market Share by Region (2014-2019) 2.3.2 Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Region (2014-2019) 3 United States Nuclear Medicine-Radiopharmaceuticals Market Analysis 3.1 United States Nuclear Medicine-Radiopharmaceuticals Consumption and Value Analysis 3.2 United States Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type 3.3 United States Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application 4 Europe Nuclear Medicine-Radiopharmaceuticals Market Analysis 4.1 Europe Nuclear Medicine-Radiopharmaceuticals Consumption and Value Analysis 4.2 Europe Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type 4.3 Europe Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application 4.4 Europe Nuclear Medicine-Radiopharmaceuticals Consumption by Top Countries 4.4.1 Germany Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 4.4.2 UK Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 4.4.3 France Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 4.4.4 Italy Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 4.4.5 Spain Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 4.4.6 Poland Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 4.4.7 Russia Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 5 China Nuclear Medicine-Radiopharmaceuticals Market Analysis 5.1 China Nuclear Medicine-Radiopharmaceuticals Consumption and Value Analysis 5.2 China Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type 5.3 China Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application 6 Japan Nuclear Medicine-Radiopharmaceuticals Market Analysis 6.1 Japan Nuclear Medicine-Radiopharmaceuticals Consumption and Value Analysis 6.2 Japan Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type 6.3 Japan Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application 7 Southeast Asia Nuclear Medicine-Radiopharmaceuticals Market Analysis 7.1 Southeast Asia Nuclear Medicine-Radiopharmaceuticals Consumption and Value Analysis 7.2 Southeast Asia Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type 7.3 Southeast Asia Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application 7.4 Southeast Asia Nuclear Medicine-Radiopharmaceuticals Consumption by Top Countries 7.4.1 Indonesia Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 7.4.2 Thailand Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 7.4.3 Philippines Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 7.4.4 Malaysia Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 7.4.5 Singapore Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 7.4.6 Vietnam Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 8 India Nuclear Medicine-Radiopharmaceuticals Market Analysis 8.1 India Nuclear Medicine-Radiopharmaceuticals Consumption and Value Analysis 8.2 India Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type 8.3 India Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application 9 Brazil Nuclear Medicine-Radiopharmaceuticals Market Analysis 9.1 Brazil Nuclear Medicine-Radiopharmaceuticals Consumption and Value Analysis 9.2 Brazil Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type 9.3 Brazil Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application 10 GCC Countries Nuclear Medicine-Radiopharmaceuticals Market Analysis 10.1 GCC Countries Nuclear Medicine-Radiopharmaceuticals Consumption and Value Analysis 10.2 GCC Countries Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type 10.3 GCC Countries Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application 10.4 GCC Countries Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Major Countries 10.4.1 Saudi Arabia Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 10.4.2 United Arab Emirates Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 10.4.3 Qatar Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 10.4.4 Bahrain Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 11 Manufacturers Profiles 11.1 Siemens Healthcare (US) 11.1.1 Business Overview 11.1.2 Products Analysis 11.1.3 Siemens Healthcare (US) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin 11.1.4 Siemens Healthcare (US) Nuclear Medicine-Radiopharmaceuticals Sales by Region 11.2 Actinium Pharmaceuticals Inc (US) 11.2.1 Business Overview 11.2.2 Products Analysis 11.2.3 Actinium Pharmaceuticals Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin 11.2.4 Actinium Pharmaceuticals Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales by Region 11.3 Cardinal Health, Inc (US) 11.3.1 Business Overview 11.3.2 Products Analysis 11.3.3 Cardinal Health, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin 11.3.4 Cardinal Health, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales by Region 11.4 Jubilant Pharma (India) 11.4.1 Business Overview 11.4.2 Products Analysis 11.4.3 Jubilant Pharma (India) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin 11.4.4 Jubilant Pharma (India) Nuclear Medicine-Radiopharmaceuticals Sales by Region 11.5 Positron Corporation (US) 11.5.1 Business Overview 11.5.2 Products Analysis 11.5.3 Positron Corporation (US) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin 11.5.4 Positron Corporation (US) Nuclear Medicine-Radiopharmaceuticals Sales by Region 11.6 Alliance Medical (UK) 11.6.1 Business Overview 11.6.2 Products Analysis 11.6.3 Alliance Medical (UK) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin 11.6.4 Alliance Medical (UK) Nuclear Medicine-Radiopharmaceuticals Sales by Region 11.7 Peregrine Pharmaceuticals, Inc. (US) 11.7.1 Business Overview 11.7.2 Products Analysis 11.7.3 Peregrine Pharmaceuticals, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin 11.7.4 Peregrine Pharmaceuticals, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales by Region 11.8 GE Healthcare (UK) 11.8.1 Business Overview 11.8.2 Products Analysis 11.8.3 GE Healthcare (UK) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin 11.8.4 GE Healthcare (UK) Nuclear Medicine-Radiopharmaceuticals Sales by Region 11.9 Triad Isotopes, Inc. (US) 11.9.1 Business Overview 11.9.2 Products Analysis 11.9.3 Triad Isotopes, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin 11.9.4 Triad Isotopes, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales by Region 11.10 Ion Beam Applications S.A (Belgium) 11.10.1 Business Overview 11.10.2 Products Analysis 11.10.3 Ion Beam Applications S.A (Belgium) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin 11.10.4 Ion Beam Applications S.A (Belgium) Nuclear Medicine-Radiopharmaceuticals Sales by Region 11.11 Bracco Imaging S.p.A (Italy) 11.11.1 Business Overview 11.11.2 Products Analysis 11.11.3 Bracco Imaging S.p.A (Italy) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin 11.11.4 Bracco Imaging S.p.A (Italy) Nuclear Medicine-Radiopharmaceuticals Sales by Region 11.12 Medi-Radiopharma Ltd (Hungary) 11.12.1 Business Overview 11.12.2 Products Analysis 11.12.3 Medi-Radiopharma Ltd (Hungary) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin 11.12.4 Medi-Radiopharma Ltd (Hungary) Nuclear Medicine-Radiopharmaceuticals Sales by Region 11.13 Lantheus Medical Imaging Inc (US) 11.13.1 Business Overview 11.13.2 Products Analysis 11.13.3 Lantheus Medical Imaging Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin 11.13.4 Lantheus Medical Imaging Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales by Region 11.14 Immunomedics, Inc. (US) 11.14.1 Business Overview 11.14.2 Products Analysis 11.14.3 Immunomedics, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin 11.14.4 Immunomedics, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Sales by Region 11.15 Alseres Pharmaceuticals, Inc (US) 11.15.1 Business Overview 11.15.2 Products Analysis 11.15.3 Alseres Pharmaceuticals, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin 11.15.4 Alseres Pharmaceuticals, Inc (US) Nuclear Medicine-Radiopharmaceuticals Sales by Region 11.16 Avid Radiopharmaceuticals (US) 11.16.1 Business Overview 11.16.2 Products Analysis 11.16.3 Avid Radiopharmaceuticals (US) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin 11.16.4 Avid Radiopharmaceuticals (US) Nuclear Medicine-Radiopharmaceuticals Sales by Region 11.17 Mallinckrodt Pharmaceuticals (Ireland) 11.17.1 Business Overview 11.17.2 Products Analysis 11.17.3 Mallinckrodt Pharmaceuticals (Ireland) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin 11.17.4 Mallinckrodt Pharmaceuticals (Ireland) Nuclear Medicine-Radiopharmaceuticals Sales by Region 11.18 Advanced Medical Isotope Corporation (US) 11.18.1 Business Overview 11.18.2 Products Analysis 11.18.3 Advanced Medical Isotope Corporation (US) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin 11.18.4 Advanced Medical Isotope Corporation (US) Nuclear Medicine-Radiopharmaceuticals Sales by Region 11.19 Bayer HealthCare Medical Care (US) 11.19.1 Business Overview 11.19.2 Products Analysis 11.19.3 Bayer HealthCare Medical Care (US) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin 11.19.4 Bayer HealthCare Medical Care (US) Nuclear Medicine-Radiopharmaceuticals Sales by Region 11.20 Nordion, Inc. (Canada) 11.20.1 Business Overview 11.20.2 Products Analysis 11.20.3 Nordion, Inc. (Canada) Nuclear Medicine-Radiopharmaceuticals Sales, Price, Revenue, Gross Margin 11.20.4 Nordion, Inc. (Canada) Nuclear Medicine-Radiopharmaceuticals Sales by Region 12 Marketing Strategy Analysis 12.1 Marketing Channel 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List 13 Global Nuclear Medicine-Radiopharmaceuticals Market Forecast (2019-2026) 13.1 Global Nuclear Medicine-Radiopharmaceuticals Consumption Volume, Revenue and Price Forecast (2019-2026) 13.1.1 Global Nuclear Medicine-Radiopharmaceuticals Consumption Volume and Growth Rate Forecast (2019-2026) 13.1.2 Global Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026) 13.1.3 Global Nuclear Medicine-Radiopharmaceuticals Price and Trend Forecast (2019-2026) 13.2 Global Nuclear Medicine-Radiopharmaceuticals Consumption Volume, Value and Growth Rate Forecast by Region (2019-2026) 13.2.1 Global Nuclear Medicine-Radiopharmaceuticals Consumption Volume and Growth Rate Forecast by Region (2019-2026) 13.2.2 Global Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast by Region (2019-2026) 13.3 Global Nuclear Medicine-Radiopharmaceuticals Consumption Volume, Revenue and Price Forecast by Type (2019-2026) 13.3.1 Global Nuclear Medicine-Radiopharmaceuticals Consumption Forecast by Type (2019-2026) 13.3.2 Global Nuclear Medicine-Radiopharmaceuticals Revenue Forecast by Type (2019-2026) 13.3.3 Global Nuclear Medicine-Radiopharmaceuticals Price Forecast by Type (2019-2026) 13.4 Global Nuclear Medicine-Radiopharmaceuticals Consumption Volume Forecast by Application (2019-2026) 14 Research Conclusions 15 Appendix 15.1 Methodology 15.2 Research Data Source

List of Tables and Figures Global Nuclear Medicine-Radiopharmaceuticals Value ($) and Growth Rate Segment by Region 2014-2026F Global Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate Segment by Product Type from 2014-2026F Global Nuclear Medicine-Radiopharmaceuticals Value ($) and Growth Rate Segment by Application 2014-2026F Figure Nuclear Medicine-Radiopharmaceuticals Picture Table Product Specifications of Nuclear Medicine-Radiopharmaceuticals Figure Global Sales Market Share of Nuclear Medicine-Radiopharmaceuticals by Type in 2018 Table Types of Nuclear Medicine-Radiopharmaceuticals Figure Diagnostic Medicine Picture Figure Therapeutic Medicine Picture Figure Nuclear Medicine-Radiopharmaceuticals Consumption Market Share by Application in 2018 Table Application of Nuclear Medicine-Radiopharmaceuticals Figure SPECT Picture Figure PET Picture Figure Therapeutic Picture Figure United States Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F) Figure Europe Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F) Figure Germany Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F) Figure UK Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F) Figure France Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F) Figure Italy Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F) Figure Spain Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F) Figure Poland Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F) Figure Russia Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F) Figure China Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F) Figure Japan Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F) Figure Southeast Asia Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F) Figure Indonesia Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F) Figure Thailand Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F) Figure Philippines Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F) Figure Malaysia Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F) Figure Singapore Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F) Figure Vietnam Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F) Figure India Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F) Figure Brazil Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F) Figure GCC Countries Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F) Figure Saudi Arabia Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F) Figure United Arab Emirates Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F) Figure Qatar Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F) Figure Bahrain Nuclear Medicine-Radiopharmaceuticals Revenue ($) and Growth Rate (2014-2026F) Table Emerging and Growing Market of Nuclear Medicine-Radiopharmaceuticals Table Industry Limitations Table Opportunities and Development Trends Figure Global Nuclear Medicine-Radiopharmaceuticals Market Size Analysis from 2014 to 2026 by Consumption Volume Figure Global Nuclear Medicine-Radiopharmaceuticals Market Size Analysis from 2014 to 2026 by Value Figure Global Nuclear Medicine-Radiopharmaceuticals Price Trends Analysis from 2014 to 2026 Table Global Nuclear Medicine-Radiopharmaceuticals Consumption and Market Share by Type (2014-2019) Table Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Type (2014-2019) Figure Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Type (2014-2019) Table Global Nuclear Medicine-Radiopharmaceuticals Consumption and Market Share by Application (2014-2019) Table Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Application (2014-2019) Figure Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Application (2014-2019) Table Global Nuclear Medicine-Radiopharmaceuticals Consumption and Market Share by Region (2014-2019) Table Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Region (2014-2019) Figure Global Nuclear Medicine-Radiopharmaceuticals Revenue and Market Share by Region (2014-2019) Figure United States Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate (2014-2019) Figure United States Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2019) Figure United States Nuclear Medicine-Radiopharmaceuticals Sales Price Analysis (2014-2019) Table United States Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type Table United States Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application Figure Europe Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate (2014-2019) Figure Europe Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2019) Figure Europe Nuclear Medicine-Radiopharmaceuticals Sales Price Analysis (2014-2019) Table Europe Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type Table Europe Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application Table Europe Nuclear Medicine-Radiopharmaceuticals Consumption by Top Countries Figure Germany Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 Figure UK Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 Figure France Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 Figure Italy Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 Figure Spain Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 Figure Poland Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 Figure Russia Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 Figure China Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate (2014-2019) Figure China Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2019) Figure China Nuclear Medicine-Radiopharmaceuticals Sales Price Analysis (2014-2019) Table China Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type Table China Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application Figure Japan Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate (2014-2019) Figure Japan Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2019) Figure Japan Nuclear Medicine-Radiopharmaceuticals Sales Price Analysis (2014-2019) Table Japan Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type Table Japan Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application Figure Southeast Asia Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate (2014-2019) Figure Southeast Asia Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2019) Figure Southeast Asia Nuclear Medicine-Radiopharmaceuticals Sales Price Analysis (2014-2019) Table Southeast Asia Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type Table Southeast Asia Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application Table Southeast Asia Nuclear Medicine-Radiopharmaceuticals Consumption by Top Countries Figure Indonesia Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 Figure Thailand Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 Figure Philippines Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 Figure Malaysia Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 Figure Singapore Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 Figure Vietnam Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 Figure India Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate (2014-2019) Figure India Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2019) Figure India Nuclear Medicine-Radiopharmaceuticals Sales Price Analysis (2014-2019) Table India Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type Table India Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application Figure Brazil Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate (2014-2019) Figure Brazil Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2019) Figure Brazil Nuclear Medicine-Radiopharmaceuticals Sales Price Analysis (2014-2019) Table Brazil Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type Table Brazil Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application Figure GCC Countries Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate (2014-2019) Figure GCC Countries Nuclear Medicine-Radiopharmaceuticals Revenue and Growth Rate (2014-2019) Figure GCC Countries Nuclear Medicine-Radiopharmaceuticals Sales Price Analysis (2014-2019) Table GCC Countries Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Type Table GCC Countries Nuclear Medicine-Radiopharmaceuticals Consumption Structure by Application Table GCC Countries Nuclear Medicine-Radiopharmaceuticals Consumption Volume by Major Countries Figure Saudi Arabia Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 Figure United Arab Emirates Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 Figure Qatar Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 Figure Bahrain Nuclear Medicine-Radiopharmaceuticals Consumption Volume from 2014 to 2019 Table Siemens Healthcare (US) Sales, Price, Revenue, Gross Margin (2014-2019) Figure Company Sales and Growth Rate Figure Company Revenue ($) Market Share 2014-2019 Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region Table Company Basic Information, Manufacturing Base Table Products Analysis Table Actinium Pharmaceuticals Inc (US) Sales, Price, Revenue, Gross Margin (2014-2019) Figure Company Sales and Growth Rate Figure Company Revenue ($) Market Share 2014-2019 Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region Table Company Basic Information, Manufacturing Base Table Products Analysis Table Cardinal Health, Inc (US) Sales, Price, Revenue, Gross Margin (2014-2019) Figure Company Sales and Growth Rate Figure Company Revenue ($) Market Share 2014-2019 Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region Table Company Basic Information, Manufacturing Base Table Products Analysis Table Jubilant Pharma (India) Sales, Price, Revenue, Gross Margin (2014-2019) Figure Company Sales and Growth Rate Figure Company Revenue ($) Market Share 2014-2019 Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region Table Company Basic Information, Manufacturing Base Table Products Analysis Table Positron Corporation (US) Sales, Price, Revenue, Gross Margin (2014-2019) Figure Company Sales and Growth Rate Figure Company Revenue ($) Market Share 2014-2019 Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region Table Company Basic Information, Manufacturing Base Table Products Analysis Table Alliance Medical (UK) Sales, Price, Revenue, Gross Margin (2014-2019) Figure Company Sales and Growth Rate Figure Company Revenue ($) Market Share 2014-2019 Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region Table Company Basic Information, Manufacturing Base Table Products Analysis Table Peregrine Pharmaceuticals, Inc. (US) Sales, Price, Revenue, Gross Margin (2014-2019) Figure Company Sales and Growth Rate Figure Company Revenue ($) Market Share 2014-2019 Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region Table Company Basic Information, Manufacturing Base Table Products Analysis Table GE Healthcare (UK) Sales, Price, Revenue, Gross Margin (2014-2019) Figure Company Sales and Growth Rate Figure Company Revenue ($) Market Share 2014-2019 Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region Table Company Basic Information, Manufacturing Base Table Products Analysis Table Triad Isotopes, Inc. (US) Sales, Price, Revenue, Gross Margin (2014-2019) Figure Company Sales and Growth Rate Figure Company Revenue ($) Market Share 2014-2019 Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region Table Company Basic Information, Manufacturing Base Table Products Analysis Table Ion Beam Applications S.A (Belgium) Sales, Price, Revenue, Gross Margin (2014-2019) Figure Company Sales and Growth Rate Figure Company Revenue ($) Market Share 2014-2019 Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region Table Company Basic Information, Manufacturing Base Table Products Analysis Table Bracco Imaging S.p.A (Italy) Sales, Price, Revenue, Gross Margin (2014-2019) Figure Company Sales and Growth Rate Figure Company Revenue ($) Market Share 2014-2019 Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region Table Company Basic Information, Manufacturing Base Table Products Analysis Table Medi-Radiopharma Ltd (Hungary) Sales, Price, Revenue, Gross Margin (2014-2019) Figure Company Sales and Growth Rate Figure Company Revenue ($) Market Share 2014-2019 Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region Table Company Basic Information, Manufacturing Base Table Products Analysis Table Lantheus Medical Imaging Inc (US) Sales, Price, Revenue, Gross Margin (2014-2019) Figure Company Sales and Growth Rate Figure Company Revenue ($) Market Share 2014-2019 Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region Table Company Basic Information, Manufacturing Base Table Products Analysis Table Immunomedics, Inc. (US) Sales, Price, Revenue, Gross Margin (2014-2019) Figure Company Sales and Growth Rate Figure Company Revenue ($) Market Share 2014-2019 Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region Table Company Basic Information, Manufacturing Base Table Products Analysis Table Alseres Pharmaceuticals, Inc (US) Sales, Price, Revenue, Gross Margin (2014-2019) Figure Company Sales and Growth Rate Figure Company Revenue ($) Market Share 2014-2019 Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region Table Company Basic Information, Manufacturing Base Table Products Analysis Table Avid Radiopharmaceuticals (US) Sales, Price, Revenue, Gross Margin (2014-2019) Figure Company Sales and Growth Rate Figure Company Revenue ($) Market Share 2014-2019 Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region Table Company Basic Information, Manufacturing Base Table Products Analysis Table Mallinckrodt Pharmaceuticals (Ireland) Sales, Price, Revenue, Gross Margin (2014-2019) Figure Company Sales and Growth Rate Figure Company Revenue ($) Market Share 2014-2019 Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region Table Company Basic Information, Manufacturing Base Table Products Analysis Table Advanced Medical Isotope Corporation (US) Sales, Price, Revenue, Gross Margin (2014-2019) Figure Company Sales and Growth Rate Figure Company Revenue ($) Market Share 2014-2019 Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region Table Company Basic Information, Manufacturing Base Table Products Analysis Table Bayer HealthCare Medical Care (US) Sales, Price, Revenue, Gross Margin (2014-2019) Figure Company Sales and Growth Rate Figure Company Revenue ($) Market Share 2014-2019 Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region Table Company Basic Information, Manufacturing Base Table Products Analysis Table Nordion, Inc. (Canada) Sales, Price, Revenue, Gross Margin (2014-2019) Figure Company Sales and Growth Rate Figure Company Revenue ($) Market Share 2014-2019 Figure Company Nuclear Medicine-Radiopharmaceuticals Sales by Region Table Company Basic Information, Manufacturing Base Table Products Analysis Figure Global Nuclear Medicine-Radiopharmaceuticals Consumption Volume and Growth Rate Forecast (2019-2026) Figure Global Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026) Figure Global Nuclear Medicine-Radiopharmaceuticals Price and Trend Forecast (2019-2026) Table Global Nuclear Medicine-Radiopharmaceuticals Consumption Volume Forecast by Region (2019-2026) Table Global Nuclear Medicine-Radiopharmaceuticals Value Forecast by Region (2019-2026) Figure United States Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026) Figure United States Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026) Figure Europe Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026) Figure Europe Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026) Figure Europe Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026) Figure Germany Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026) Figure Germany Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026) Figure UK Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026) Figure UK Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026) Figure France Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026) Figure France Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026) Figure Italy Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026) Figure Italy Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026) Figure Spain Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026) Figure Spain Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026) Figure Poland Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026) Figure Poland Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026) Figure Russia Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026) Figure Russia Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026) Figure China Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026) Figure China Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026) Figure Japan Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026) Figure Japan Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026) Figure Southeast Asia Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026) Figure Southeast Asia Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026) Figure Indonesia Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026) Figure Indonesia Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026) Figure Thailand Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026) Figure Thailand Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026) Figure Philippines Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026) Figure Philippines Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026) Figure Malaysia Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026) Figure Malaysia Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026) Figure Singapore Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026) Figure Singapore Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026) Figure Vietnam Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026) Figure Vietnam Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026) Figure India Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026) Figure India Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026) Figure Brazil Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026) Figure Brazil Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026) Figure GCC Countries Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026) Figure GCC Countries Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026) Figure Saudi Arabia Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026) Figure Saudi Arabia Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026) Figure United Arab Emirates Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026) Figure United Arab Emirates Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026) Figure Qatar Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026) Figure Qatar Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026) Figure Bahrain Nuclear Medicine-Radiopharmaceuticals Consumption and Growth Rate Forecast (2019-2026) Figure Bahrain Nuclear Medicine-Radiopharmaceuticals Value and Growth Rate Forecast (2019-2026) Table Global Nuclear Medicine-Radiopharmaceuticals Consumption Forecast by Type (2019-2026) Table Global Nuclear Medicine-Radiopharmaceuticals Revenue Forecast by Type (2019-2026) Figure Global Nuclear Medicine-Radiopharmaceuticals Price Forecast by Type (2019-2026) Table Global Nuclear Medicine-Radiopharmaceuticals Consumption Volume Forecast by Application (2019-2026)